Aussie scientists uncover surprising twists in malaria, breast cancer research

Australians scientists have made groundbreaking discoveries in the fields of malaria and breast cancer research, revealing complex interactions within the body's response to disease.

In a study led by the Walter and Eliza Hall Institute of Medical Research, researchers developed a novel malaria vaccination strategy that could enhance immunity upon subsequent mosquito bites. By combining malaria parasites delivered by mosquitoes with antimalarial compounds that trap parasites in the liver, the immune system is given time to respond effectively without the parasites progressing to full infection.

This "vaccinate and boost naturally" approach was effective in mice for up to two years, potentially leading to long-lasting protection in malaria-prone regions.

Meanwhile, researchers at the Peter MacCallum Cancer Centre uncovered a surprising connection between a cancer-fighting protein and breast cancer treatment resistance. The retinoblastoma (Rb) protein, known for its role in preventing uncontrolled cell division, was found to also activate genes that respond to oestrogen. Some of these genes may help cancer cells survive treatment and continue to grow.

This discovery, published in "Nature", could explain why certain combination therapies, such as CDK4/6 inhibitors and endocrine therapy, become less effective when tumours become resistant. Understanding this mechanism could guide the development of new drug combinations to delay resistance and improve treatment outcomes for breast cancer patients.